Larimar Therapeutics (LRMR) Q4 2025 Earnings

Nov 5Confirmed
Q4 2024
Q2 2025
Q3 2025
Q4 2025
-0.61
-0.49
-0.36
-0.24

Details

Expected EPS
-0.403694
Actual EPS
-0.61
Surprise EPS
-0.21
Surprise Percent
-51.1%

Description

⁨Larimar Therapeutics⁩ (⁦LRMR⁩) has reported earnings of ⁦-0.61⁩ per share for ⁦Q4 2025⁩.

0 Comments

Share your thoughts